Margo Sorgman was diagnosed with an MPN, polycythemia vera (PV), just a few months ago at the age of 71. She shares her story of learning about the condition, meeting with Dr. Brady Stein, and how she’s doing today.
Jeff Folloder, a husband, father, son, and cancer survivor, discusses his own personal journey with CLL and his philanthropic efforts in the cancer community.
Why do I have lung cancer if I’ve never smoked? Dianne Stewart, a stage IV cancer patient, asked herself this question following her diagnosis. Hear about her initial stage of shock and denial and her advice for others.
April 22, 2011
In this podcast, Dr. Sato will discuss thermal ablation and how someone with a kidney or liver tumor may benefit from this new treatment. He will explain how it is performed and what one can expect after receiving thermal ablation.
View more programs featuring
Kent Sato, M.D. and Rick Marrazzo
Produced in association with
Kent Sato, M.D.
Be the first to know about new programs and information with email alerts.
Thermal ablation, a minimally invasive therapy, is showing great promise in treating liver and kidney tumors. What is thermal ablation, and who could benefit from this approach? Here to answer these questions and more is Dr. Kent Sato from Northwestern Memorial Hospital in Chicago. And you'll also hear from his patient, Rick Marrazzo, as he shares his story. It's all next on Patient Power.
Hello and welcome to Patient Power sponsored by Northwestern Memorial Hospital. I'm Andrew Schorr. Well, there are some serious diagnoses where sometimes they may be talking about surgery, and some people might be candidates for surgery if, for example, they found a tumor in your kidney or they saw tumors in your liver. However, for some patients there are alternate approaches. One approach could be something called thermal ablation, where doctors might use the freezing or heating of the cancer cells to try to kill them, and you would not have an open surgery.
Published: November 18, 2008
Published: December 1, 2008
Published: April 19, 2007
Published: July 1, 2008
Published: August 14, 2008
By Andrew Schorr